An H5N1 M2e-based multiple antigenic peptide vaccine confers heterosubtypic protection from lethal infection with pandemic 2009 H1N1 virus
<p>Abstract</p> <p>Background</p> <p>A 2009 global influenza pandemic caused by a novel swine-origin H1N1 influenza A virus has posted an increasing threat of a potential pandemic by the highly pathogenic avian influenza (HPAI) H5N1 virus, driving us to develop an influ...
Main Authors: | Yu Hong, Guo Yan, Kou Zhihua, Ru Zhitao, Xiao Wenjun, Du Lanying, Sun Shihui, Zhao Guangyu, Jiang Shibo, Lone Yuchun, Zheng Bo-Jian, Zhou Yusen |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2010-07-01
|
Series: | Virology Journal |
Online Access: | http://www.virologyj.com/content/7/1/151 |
Similar Items
-
Changes in heterosubtypic antibody responses during the first year of the 2009 A(H1N1) influenza pandemic
by: Freidl, G, et al.
Published: (2016) -
Age-related sensitivity and pathological differences in infections by 2009 pandemic influenza A (H1N1) virus
by: Wu Xiaohong, et al.
Published: (2011-02-01) -
Heterosubtypic cross-reactivity of HA1 antibodies to influenza A, with emphasis on nonhuman subtypes (H5N1, H7N7, H9N2).
by: Dennis E Te Beest, et al.
Published: (2017-01-01) -
A non-VH1-69 heterosubtypic neutralizing human monoclonal antibody protects mice against H1N1 and H5N1 viruses.
by: Donata De Marco, et al.
Published: (2012-01-01) -
H1 Hemagglutinin Priming Provides Long-Lasting Heterosubtypic Immunity against H5N1 Challenge in the Mouse Model
by: Juan Manuel Carreño, et al.
Published: (2020-12-01)